New COVID-19 Diagnostics Urgently Needed As The Current Nasal or Saliva Swabs Tests Are Unable To Detect Viral Persistence Let Alone New Variants!
It is amazing and shocking as to how the global medical community has been addressing a global pandemic that has been plaguing the world for the last 31 months with a new pathogen outbreak that involves a novel virus that we still know little about and worse is constantly evolving and changing the ways of not only how it evades human host immunity… both natural and vaccine induced but also its pathogenesis.
The medical community are still working with so many unknowns from the actual incubation periods of the virus and its emerging variants, their shedding periods and even updated details of its ever-evolving ways that it affects the various human cellular pathways, gene dysregulation and damage of the various cells, tissues and organs.
One of the most ridiculous things that to date has not been updated is the COVID-19 diagnostics that are being used. The world is still are still using a primitive tool that involves nasal or saliva swabs that are either then tested using PCR platforms or rapid antigen kits, to determine if a person has COVID-19 or has ‘recovered from COVID-19.”
We already now know that SARS-CoV-2 is simply not just a respiratory virus and that it is able to affect literally every part of the human body as it uses a multiple number of receptors and ways to gain entry into various host cells.
We now have evidence that besides being able to infect via airborne transmissions, the virus is also spreadable via water borne and food borne transmissions and even by zoonotic transmissions.
It is already known that the SARS-CoV-2 is also neurotropic, cardiotropic, hepatotropic and even nephrotropic etc.
We already have evidence that SARS-CoV-2 viral persistence is a serious concern and that the SARS-CoV-2 is able to hide in various tissues and organs in the human host and that there are so called ‘reservoirs’ of these viruses in various ‘compartments of the human body.
The current COVID-19 diagnostics
used are not able to determine viral persistence and worse is no longer reliable especially when dealing with the newer emerging variants that are displaying varying tropisms and replication sites.
It is already a known fact that many who were deemed as recovered by these COVID-19 diagnostics actually have ‘continued infection states’ in various parts of their bodies.
With the current global surge involving the new BA.4 and BA.5 variants and subvariants, the new BA.2.75, BA.2.77 and BA.2.78 variants, there are increasing reports that infected individuals despite manifesting symptoms are still testing negative for days with either PCR platforms or even rapid antigen test kits. It is only days later, that some eventually test positive.
That is also one of the reasons that many health authorities are no longer focusing on testing although they are not divulging the fact that the current diagnostics are not reliable.
Furthermore, unreliable testing also helps the pharma companies get away with claims that their therapeutics are working or helping in the treatment of COVID-19.
In reality, we are facing the new variants without any effective antivirals,
prophylactics or even therapeutics. All that the U.S. FDA and certain entities like the FLCC have been pushing are merely placebos and worse some are actually toxic and can have long term damaging effects.
Its amazing how we have been blindly navigating this pandemic for the last 31 months.
The long-term effects of viral persistence and even reinfections that are not properly being detected are going to have a catastrophic effect on many.
Already we at Thailand Medical News
predicts that majority infected with the SARS-CoV-2 will have shortened lifespans. https://www.thailandmedical.news/news/breaking-hypothesis-that-majority-exposed-to-sars-cov-2-will-have-shortened-lifespans-validated-by-study-showing-nsp2-impairs-human-4ehp-gigyf2-comple
For the latest of the COVID-19 Crisis
, keep on logging to Thailand Medical News